Skip to main content
. Author manuscript; available in PMC: 2021 Dec 16.
Published in final edited form as: Heart. 2019 Dec 10;106(8):562–568. doi: 10.1136/heartjnl-2019-314810

Figure 3.

Figure 3

Clinical studies with CMR-assessed cardiac fibrosis in SCD (SCA, HbSC, HbS-thalassemia). CMR, cardiac magnetic resonance; SCD, sickle cell disease.

Definitions: N, number of study participants; %, percentage of study participants with the feature; Mass/Diam, mass or diameter; LVDD, left ventricular diastolic dysfunction; LVEF, left ventricular ejection fraction (PEF, preserved ejection fraction; REF, reduced ejection fraction); LGE, late gadolinium enhancement; ECV, extracellular volume; T, increased versus normal; 4-, decreased versus normal; RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle; na, no available data.